Role of visceral adipose tissue in aging

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 10, 2009, Pages 1117-1123

  Huffman, Derek M ^a   Barzilai, Nir ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Longevity; Metabolic syndrome; Obesity; Restriction; Visceral fat

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR2 ANTAGONIST; LEPTIN; OXIDOREDUCTASE INHIBITOR; PIOGLITAZONE; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; AGING; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY FAT DISTRIBUTION; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; DEATH; DRUG MECHANISM; ENERGY METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIFESPAN; LIPOSUCTION; LONGEVITY; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SUBCUTANEOUS FAT; SURGICAL APPROACH; TRANSGENIC ANIMAL; TREATMENT PLANNING;

AGING; ALZHEIMER DISEASE; ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MODELS, BIOLOGICAL; NEOPLASMS;

MUS; RATTUS; RODENTIA;

EID: 69949106011     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.01.008     Document Type: Review

References (87)

1. Monzillo L.U., Hamdy O., Horton E.S., Ledbury S., Mullooly C., Jarema C., Porter S., Ovalle K., Moussa A., and Mantzoros C.S. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes. Res. 11 (2003) 1048-1054
2. Ramas J., Courbon A., Roche F., Bethoux F., and Calmels P. Effect of training programs and exercise in adult stroke patients: literature review. Ann. Readapt. Med. Phys. 50 (2007) 438-444
3. Gaesser G.A. Exercise for prevention and treatment of cardiovascular disease, type 2 diabetes, and metabolic syndrome. Curr. Diab. Rep. 7 (2007) 14-19
4. McAuley P.A., Myers J.N., Abella J.P., Tan S.Y., and Froelicher V.F. Exercise capacity and body mass as predictors of mortality among male veterans with type 2 diabetes. Diabetes Care 30 (2007) 1539-1543
5. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., and Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 163 (2003) 427-436
6. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., and Heath Jr. C.W. Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 341 (1999) 1097-1105
7. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348 (2003) 1625-1638
8. Freedland S.J. Obesity and prostate cancer: importance of race and stage of disease. J. Urol. 178 (2007) 1842-1843
9. Abrahamson P.E., Gammon M.D., Lund M.J., Flagg E.W., Porter P.L., Stevens J., Swanson C.A., Brinton L.A., Eley J.W., and Coates R.J. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol. Biomarkers. Prev. 15 (2006) 1871-1877
10. Samanic C., Chow W.H., Gridley G., Jarvholm B., and Fraumeni Jr. J.F. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17 (2006) 901-909
11. Dignam J.J., Polite B.N., Yothers G., Raich P., Colangelo L., O'Connell M.J., and Wolmark N. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J. Natl. Cancer Inst. 98 (2006) 1647-1654
12. Pavelka J.C., Brown R.S., Karlan B.Y., Cass I., Leuchter R.S., Lagasse L.D., and Li A.J. Effect of obesity on survival in epithelial ovarian cancer. Cancer 107 (2006) 1520-1524
13. Chia V.M., Newcomb P.A., Trentham-Dietz A., and Hampton J.M. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int. J. Gynecol. Cancer 17 (2007) 441-446
14. Carr D.B., Utzschneider K.M., Hull R.L., Kodama K., Retzlaff B.M., Brunzell J.D., Shofer J.B., Fish B.E., Knopp R.H., and Kahn S.E. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53 (2004) 2087-2094
15. Bjorntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10 (1990) 493-496
16. Trayhurn P., and Wood I.S. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans. 33 (2005) 1078-1081
17. Selwyn A.P. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update. Am. J. Cardiol. 100 (2007) 33P-37P
18. Matsuzawa Y., Shimomura I., Nakamura T., Keno Y., and Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Ann. N. Y. Acad. Sci. 748 (1995) 399-406
19. Koh-Banerjee P., Wang Y., Hu F.B., Spiegelman D., Willett W.C., and Rimm E.B. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am. J. Epidemiol. 159 (2004) 1150-1159
20. Pascot A., Lemieux S., Lemieux I., Prud'homme D., Tremblay A., Bouchard C., Nadeau A., Couillard C., Tchernof A., Bergeron J., and Despres J.P. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 22 (1999) 1471-1478
21. Walker S.P., Rimm E.B., Ascherio A., Kawachi I., Stampfer M.J., and Willett W.C. Body size and fat distribution as predictors of stroke among US men. Am. J. Epidemiol. 144 (1996) 1143-1150
22. Nicklas B.J., Cesari M., Penninx B.W., Kritchevsky S.B., Ding J., Newman A., Kitzman D.W., Kanaya A.M., Pahor M., and Harris T.B. Abdominal obesity is an independent risk factor for chronic heart failure in older people. J. Am. Geriatr. Soc. 54 (2006) 413-420
23. Whitmer R.A., Gustafson D.R., Barrett-Connor E., Haan M.N., Gunderson E.P., and Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 71 (2008) 1057-1064
24. Razay G., Vreugdenhil A., and Wilcock G. Obesity, abdominal obesity and Alzheimer disease. Dement. Geriatr. Cogn. Disord. 22 (2006) 173-176
25. Guallar-Castillon P., Sagardui-Villamor J., Banegas J.R., Graciani A., Fornes N.S., Lopez Garcia E., and Rodriguez-Artalejo F. Waist circumference as a predictor of disability among older adults. Obesity. (Silver Spring) 15 (2007) 233-244
26. Robles-Cervantes J.A., Yanez-Diaz S., and Cardenas-Camarena L. Modification of insulin, glucose and cholesterol levels in nonobese women undergoing liposuction: is liposuction metabolically safe?. Ann. Plast. Surg. 52 (2004) 64-67
27. Giese S.Y., Bulan E.J., Commons G.W., Spear S.L., and Yanovski J.A. Improvements in cardiovascular risk profile with large-volume liposuction: a pilot study. Plast. Reconstr. Surg. 108 (2001) 510-519 discussion 520-1
28. Gonzalez-Ortiz M., Robles-Cervantes J.A., Cardenas-Camarena L., Bustos-Saldana R., and Martinez-Abundis E. The effects of surgically removing subcutaneous fat on the metabolic profile and insulin sensitivity in obese women after large-volume liposuction treatment. Horm. Metab. Res. 34 (2002) 446-449
29. Samdal F., Birkeland K.I., Ose L., and Amland P.F. Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females. Aesthetic. Plast. Surg. 19 (1995) 131-135
30. Enzi G., Cagnoni G., Baritussio A., De Biasi F., Favaretto L., Inelmen E.M., and Crepaldi G. Effects of fat mass reduction by dieting and by lipectomy on carbohydrate metabolism in obese patients. Acta Diabetol. Lat. 16 (1979) 147-156
31. Lambert E.V., Hudson D.A., Bloch C.E., and Koeslag J.H. Metabolic response to localized surgical fat removal in nonobese women. Aesthetic. Plast. Surg. 15 (1991) 105-110
32. Ybarra J., Blanco-Vaca F., Fernandez S., Castellvi A., Bonet R., Palomer X., Ordonez-Llanos J., Trius A., Vila-Rovira R., and Perez A. The effects of liposuction removal of subcutaneous abdominal fat on lipid metabolism are independent of insulin sensitivity in normal-overweight individuals. Obes. Surg. 18 (2008) 408-414
33. Klein S., Fontana L., Young V.L., Coggan A.R., Kilo C., Patterson B.W., and Mohammed B.S. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N. Engl. J. Med. 350 (2004) 2549-2557
34. Buettner R., Scholmerich J., and Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity. (Silver Spring) 15 (2007) 798-808
35. Kim S.P., Catalano K.J., Hsu I.R., Chiu J.D., Richey J.M., and Bergman R.N. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1590-E1598
36. Powell C.S., Blaylock M.L., Wang R., Hunter H.L., Johanning G.L., and Nagy T.R. Effects of energy expenditure and Ucp1 on photoperiod-induced weight gain in collard lemmings. Obes. Res. 10 (2002) 541-550
37. Davey R.A., and MacLean H.E. Current and future approaches using genetically modified mice in endocrine research. Am. J. Physiol. Endocrinol. Metab. 291 (2006) E429-E438
38. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
39. Bjorntorp P. Hormonal control of regional fat distribution. Hum. Reprod. 12 Suppl 1 (1997) 21-25
40. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001) 2166-2170
41. Ohman M.K., Shen Y., Obimba C.I., Wright A.P., Warnock M., Lawrence D.A., and Eitzman D.T. Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117 (2008) 798-805
42. Barzilai N., She L., Liu B.Q., Vuguin P., Cohen P., Wang J., and Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48 (1999) 94-98
43. Einstein F.H., Fishman S., Muzumdar R.H., Yang X.M., Atzmon G., and Barzilai N. Accretion of visceral fat and hepatic insulin resistance in pregnant rats. Am. J. Physiol. Endocrinol. Metab. 294 (2008) E451-E455
44. Borst S.E., Conover C.F., and Bagby G.J. Association of resistin with visceral fat and muscle insulin resistance. Cytokine 32 (2005) 39-44
45. Gabriely I., Ma X.H., Yang X.M., Atzmon G., Rajala M.W., Berg A.H., Scherer P., Rossetti L., and Barzilai N. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 51 (2002) 2951-2958
46. Pitombo C., Araujo E.P., De Souza C.T., Pareja J.C., Geloneze B., and Velloso L.A. Amelioration of diet-induced diabetes mellitus by removal of visceral fat. J. Endocrinol. 191 (2006) 699-706
47. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., Schraw T., Durand J.L., Li H., Li G., Jelicks L.A., Mehler M.F., Hui D.Y., Deshaies Y., Shulman G.I., Schwartz G.J., and Scherer P.E. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117 (2007) 2621-2637
48. Rissanen A., Heliovaara M., Knekt P., Aromaa A., Reunanen A., and Maatela J. Weight and mortality in Finnish men. J. Clin. Epidemiol. 42 (1989) 781-789
49. Lindsted K., Tonstad S., and Kuzma J.W. Body mass index and patterns of mortality among Seventh-day Adventist men. Int. J. Obes. 15 (1991) 397-406
50. Bender R., Jockel K.H., Trautner C., Spraul M., and Berger M. Effect of age on excess mortality in obesity. Jama 281 (1999) 1498-1504
51. Allison D.B., Fontaine K.R., Manson J.E., Stevens J., and VanItallie T.B. Annual deaths attributable to obesity in the United States. JAMA 282 (1999) 1530-1538
52. Fontaine K.R., Redden D.T., Wang C., Westfall A.O., and Allison D.B. Years of life lost due to obesity. JAMA 289 (2003) 187-193
53. Valdes A.M., Andrew T., Gardner J.P., Kimura M., Oelsner E., Cherkas L.F., Aviv A., and Spector T.D. Obesity, cigarette smoking, and telomere length in women. Lancet 366 (2005) 662-664
54. Stevens J., Keil J.E., Rust P.F., Tyroler H.A., Davis C.E., and Gazes P.C. Body mass index and body girths as predictors of mortality in black and white women. Arch. Intern. Med. 152 (1992) 1257-1262
55. Folsom A.R., Kaye S.A., Sellers T.A., Hong C.P., Cerhan J.R., Potter J.D., and Prineas R.J. Body fat distribution and 5-year risk of death in older women. JAMA 269 (1993) 483-487
56. Baik I., Ascherio A., Rimm E.B., Giovannucci E., Spiegelman D., Stampfer M.J., and Willett W.C. Adiposity and mortality in men. Am. J. Epidemiol. 152 (2000) 264-271
57. Wannamethee S.G., Shaper A.G., Lennon L., and Whincup P.H. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am. J. Clin. Nutr. 86 (2007) 1339-1346
58. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K., van der Schouw Y.T., Spencer E., Moons K.G., Tjonneland A., Halkjaer J., Jensen M.K., Stegger J., Clavel-Chapelon F., Boutron-Ruault M.C., Chajes V., Linseisen J., Kaaks R., Trichopoulou A., Trichopoulos D., Bamia C., Sieri S., Palli D., Tumino R., Vineis P., Panico S., Peeters P.H., May A.M., Bueno-de-Mesquita H.B., van Duijnhoven F.J., Hallmans G., Weinehall L., Manjer J., Hedblad B., Lund E., Agudo A., Arriola L., Barricarte A., Navarro C., Martinez C., Quiros J.R., Key T., Bingham S., Khaw K.T., Boffetta P., Jenab M., Ferrari P., and Riboli E. General and abdominal adiposity and risk of death in Europe. N. Engl. J. Med. 359 (2008) 2105-2120
59. Tannenbaum A. The genesis and growth of tumors. II. Effects of caloric restriction per se. Cancer Res. 2 (1942) 460-464
60. Tannenbaum A. The dependence of the genesis of induced skin tumors on the caloric intake during different stages of carcinogenesis. Cancer Res. 4 (1944) 673-679
61. Nutrition classics, The American Journal of Cancer, Volume XXXVIII, March, 1940: The initiation and growth of tumors. Introduction. I. Effects of underfeeding. By Albert Tannenbaum Nutr Rev 45 (1987) 20-2.
62. R. Weindruch, R. Walford, The Retardation of Aging and Disease by Dietary Restriction, C.C. Thomas, Springfield IL, 1988.
63. Masoro E.J. Overview of caloric restriction and ageing. Mech. Ageing Dev. 126 (2005) 913-922
64. Kealy R.D., Lawler D.F., Ballam J.M., Mantz S.L., Biery D.N., Greeley E.H., Lust G., Segre M., Smith G.K., and Stowe H.D. Effects of diet restriction on life span and age-related changes in dogs. J. Am. Vet. Med. Assoc. 220 (2002) 1315-1320
65. Roth G.S., Ingram D.K., and Lane M.A. Caloric restriction in primates and relevance to humans. Ann. N. Y. Acad. Sci. 928 (2001) 305-315
66. Pinney D.O., Stephens D.F., and Pope L.S. Lifetime effects of winter supplemental feed level and age at first parturition on range beef cows. J. Anim. Sci. 34 (1972) 1067-1074
67. Pugh T.D., Klopp R.G., and Weindruch R. Controlling caloric consumption: protocols for rodents and rhesus monkeys. Neurobiol. Aging 20 (1999) 157-165
68. Bertrand H.A., Lynd F.T., Masoro E.J., and Yu B.P. Changes in adipose mass and cellularity through the adult life of rats fed ad libitum or a life-prolonging restricted diet. J. Gerontol. 35 (1980) 827-835
69. Masoro E.J. Commentary on "Revisiting the role of fat mass in the life extension induced by caloric restriction". J. Gerontol. A. Biol. Sci. Med. Sci. 54A (1999) B97
70. Speakman J.R. Body size, energy metabolism and lifespan. J. Exp. Biol. 208 (2005) 1717-1730
71. Bluher M., Kahn B.B., and Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299 (2003) 572-574
72. Barzilai N., and Gupta G. Revisiting the role of fat mass in the life extension induced by caloric restriction. J. Gerontol. A. Biol. Sci. Med. Sci. 54 (1999) B89-96 discussion B97-8
73. Harrison D.E., Archer J.R., and Astle C.M. Effects of food restriction on aging: separation of food intake and adiposity. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 1835-1838
74. Berg B.N., and Simms H.S. Nutrition and longevity in the rat. II. Longevity and onset of disease with different levels of food intake. J. Nutr. 71 (1960) 255-263
75. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
76. Fontana L., Meyer T.E., Klein S., and Holloszy J.O. Long-term low-calorie low-protein vegan diet and endurance exercise are associated with low cardiometabolic risk. Rejuvenation Res. 10 (2007) 225-234
77. Rose D.P., Komninou D., and Stephenson G.D. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes. Rev. 5 (2004) 153-165
78. Frankenberry K.A., Somasundar P., McFadden D.W., and Vona-Davis L.C. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am. J. Surg. 188 (2004) 560-565
79. Barzilai N., Banerjee S., Hawkins M., Chen W., and Rossetti L. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J. Clin. Invest. 101 (1998) 1353-1361
80. Weindruch R. The retardation of aging by caloric restriction: studies in rodents and primates. Toxicol. Pathol. 24 (1996) 742-745
81. Wang C., Weindruch R., Fernandez J.R., Coffey C.S., Patel P., and Allison D.B. Caloric restriction and body weight independently affect longevity in Wistar rats. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 357-362
82. Muzumdar R., Allison D.B., Huffman D.M., Ma X., Atzmon G., Einstein F.H., Fishman S., Poduval A.D., McVei T., Keith S.W., and Barzilai N. Visceral adipose tissue modulates mammalian longevity. Aging Cell. 7 (2008) 438-440
83. Barzilai N., Wang J., Massilon D., Vuguin P., Hawkins M., and Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J. Clin. Invest. 100 (1997) 3105-3110
84. Barzilai N., and Gabriely I. The role of fat depletion in the biological benefits of caloric restriction. J. Nutr. 131 (2001) 903S-906S
85. Hermanowski-Vosatka A., Balkovec J.M., Cheng K., Chen H.Y., Hernandez M., Koo G.C., Le Grand C.B., Li Z., Metzger J.M., Mundt S.S., Noonan H., Nunes C.N., Olson S.H., Pikounis B., Ren N., Robertson N., Schaeffer J.M., Shah K., Springer M.S., Strack A.M., Strowski M., Wu K., Wu T., Xiao J., Zhang B.B., Wright S.D., and Thieringer R. 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J. Exp. Med. 202 (2005) 517-527
86. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R.L., and Ferrante Jr. A.W. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116 (2006) 115-124
87. Kim Y.W., Kim J.Y., and Lee S.K. Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue in monosodium glutamate (MSG)-obese rats. J. Korean Med. Sci. 14 (1999) 539-545